Aribio’s Four Hyaluronic Acid Fillers Receive Product Approval in Indonesia
Four Types of "Bidan" Approved
Discussions Underway with Local Aesthetic Companies for Supply and Product Launch
Aribio and AribioLab announced on September 8, 2026, that four types of their self-developed hyaluronic acid (HA) filler brand "Bidan" have received product approval from Indonesia’s National Food and Drug Agency (BPOM).
"Bidan" is an HA filler that Aribio Group spent seven years developing for the anti-aging and medical aesthetics market. The product applies Aribio’s proprietary "PCRT" technology, which enhances the uniformity and viscoelasticity of HA particles, and incorporates the "HCCL" process to reduce residual crosslinkers.
According to Aribio, the product’s biocompatibility, efficacy, and safety were verified through human application tests led by Professor Heo Changhoon’s team from the Department of Dermatology at Seoul National University Bundang Hospital. Based on these results, Aribio obtained marketing approval in Korea.
With a population of approximately 300 million, Indonesia is the world’s fourth most populous country, and its medical aesthetics market continues to expand alongside economic growth.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Aribio Group is currently in discussions with local aesthetics companies regarding supply and product launches, following the BPOM product approval. The group plans to secure local distribution networks and accelerate its entry into the Indonesian market.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.